The panel of outside experts for the Food and Drug Administration agreed that a pivotal study in patients failed to show “strong evidence” that the drug worked.
Some of the federal government’s top health officials are suggesting a vaccine for COVID-19 could be released in less than two months. The move would be made through a special emergency authorization of the Food and Drug Administration. But the…
Questions are again being raised about whether the Trump administration is injecting politics into science -- and the national pandemic response. Recent moves by the Food and Drug Administration and the Centers for Disease Control and Prevention appear to conflict…
In our news wrap Monday, the U.S. Food and Drug Administration withdrew emergency approval for hospitals to use hydroxychloroquine to treat COVID-19. The FDA said the malaria drug is unlikely to be effective against the coronavirus. Meanwhile, infections continue to…
The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus.
The test is used daily at the White House to test President Donald Trump and key members of his staff, including the coronavirus task force.
In our news wrap Wednesday, U.S. intelligence believes that China vastly understated its own death toll in the COVID-19 pandemic. Two senior U.S. officials say the true number of dead in Wuhan, where the outbreak began, could be 10 times…
Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.
The Food and Drug Administration declined to identify the manufacturer or the product.
The Food and Drug Administration has approved the first treatment for children with peanut allergies.
Additional Support Provided By:
